Enomark Pharma Private Limited

Enomark Pharma Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U51909MH2016PTC282093 Incorporated 06 June 2016 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma MSME · Micro
Revenue · FY 2025
₹2.56 Cr
▲ 172% YoY
Net loss · FY 2025
₹26.85 Lakh
Net margin -10.5%
EBITDA · FY 2025
-₹12.15 Lakh
EBITDA margin -4.7%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹1 Cr
Issued & subscribed
Open charges
₹7.5 Cr
Secured borrowings
Company age
10 yrs
Est. 2016
Directors on board
4
As per MCA filings

About Enomark Pharma Private Limited

Data last updated:

Enomark Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 06 June 2016 and has been in existence for over 10 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2016PTC282093. Its GSTIN is 08AAPCA5656A1ZN (Rajasthan). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹1 Cr. It was formerly known as Aerozest Life Science Private Limited. It is led by directors including Shriram Sawalram Patel (Managing Director) and Umesh Ruparam Patel.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1/A 25 Manali Bldg No. 1 Chs Ltd Evershine Nagar Malad West, Mumbai, Maharashtra, India – 400064.

As per the financials filed for FY 2025, the company reported a revenue of ₹2.56 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹26.85 Lakh (net margin -10.5%) and EBITDA of -₹12.15 Lakh (EBITDA margin -4.7%). Revenue has grown at a compounded annual rate (CAGR) of 388% over three years and 29% over five years.

Its group structure includes 3 subsidiaries.

As per MCA filings, the company has open charges of ₹7.5 Cr on record.

Enomark Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0147566). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U51909MH2016PTC282093
Registration Number 282093
Incorporation Date 06 June 2016
ROC Mumbai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-19-0147566

Recognitions & Rankings of Enomark Pharma

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-MH-19-0147566

Contact details

Enomark Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    1/A 25 Manali Bldg No. 1 Chs Ltd Evershine Nagar Malad West, Mumbai, Maharashtra, India – 400064
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Enomark Pharma Private Limited, buy the company report.

Comprehensive company report
Enomark Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Enomark Pharma is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturing21Manufacture of basic pharmaceutical products and pharmaceutical preparations

To see the full business activity and turnover split of Enomark Pharma Private Limited, buy the company report.

Financials of Enomark Pharma Private Limited

FY 2025 filings available

Enomark Pharma Private Limited reported revenue of ₹2.56 Cr (up 172% YoY) for FY 2025.

Revenue · FY 2025
₹2.56 Cr ▲ 172%
Net loss · FY 2025
₹26.85 Lakh margin -10.5%
EBITDA · FY 2025
-₹12.15 Lakh margin -4.7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 172%
3 years · compounded
▲ 388%
5 years · compounded
▲ 29%
EBITDA CAGR growth
1 year
▼ 944%
3 years · compounded
▼ 190%
5 years · compounded
▼ 77%

Revenue has grown at a compounded annual rate (CAGR) of 29% over five years, including 172% growth in the latest year. EBITDA fell 944% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹12.15 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹26.85 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-4.7%
Net Profit Margin-10.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Enomark Pharma Private Limited, buy the company report.

Board of directors of Enomark Pharma Private Limited

Enomark Pharma has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Shriram Sawalram PatelManaging Director21 Jan 20224 Years 10 MonthsCurrent
Umesh Ruparam PatelDirector21 Jan 20224 Years 10 MonthsCurrent
Jetharam PatelDirector14 Jun 20242 Years 5 MonthsCurrent
Laxmanram Ruparam PatelDirector30 Sep 20233 Years 1 MonthsCurrent

Auditor

Enomark Pharma Private Limited is audited by Abdul Rahim & Associates for the financial year 2023.

Auditor firmFinancial yearFirm registration number
Abdul Rahim & AssociatesFY 2023140943W

Shareholding

The shareholding of Enomark Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2021FY 2020FY 2019FY 2018
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Enomark Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
₹7.5 Cr
Satisfied charges
None
Breakdown by lending institutions
Others₹7.50 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
06 Mar 2024100907656Others₹7.5 CrOpen

To see the full charge records of Enomark Pharma Private Limited, buy the company report.

Total charge records: 1 View all charges

MSME payment delays

Enomark Pharma Private Limited has 1 MSME Form 1 return on record for the period ending Jan 2019, listing 2 overdue payments to 2 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (2 of 2)

SupplierAmount dueDue sinceReported on
an individual supplier
Enomark Healthcare Private Limited

To see the full MSME payment records of Enomark Pharma Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Group structure & subsidiaries

Enomark Pharma has 3 subsidiary companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.

3
Subsidiary companies
Key subsidiaries
Company NameCINShares held
Karkinos Lifescience Private LimitedU24230MH2023PTC397830
Glenwell Healthcare Private LimitedU85110RJ2022PTC081640
Medicopia Pharma Private LimitedU85300RJ2022PTC084397

To see the full group structure of Enomark Pharma Private Limited, buy the company report.

GST

Enomark Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
08AAPCA5656A1ZNRajasthanActive05 Jul 2022

To see the full GST registrations and return filing status of Enomark Pharma Private Limited, buy the company report.

Recent activity

Enomark Pharma Private Limited has 12 board changes on record since 2016: 8 appointments and 4 cessations. The latest: Gopa Ram ceased to be Director on 14 Jun 2024.

AGM
Enomark Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others of Rs. 7.50 Cr registered on 06 Mar 2024 with Charge ID 100907656 was modified on 09 Apr 2025.
Filing
Enomark Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Ceased
Gopa Ram ceased to be Director.
Appointed
Jetharam Patel was appointed as Director.
Charges
A charge with Others amounted to Rs. 7.50 Cr with Charge ID 100907656 was registered on 06 Mar 2024.
Appointed
Laxmanram Ruparam Patel was appointed as Director.
Ceased
Hiteshkumar Chandulal Patel ceased to be Director.
Ceased
Idanram Bhakarram Patel ceased to be Director.
Ceased
Mangalaram Galaramji Choudhary ceased to be Managing Director.
Appointed
Gopa Ram was appointed as Director.
Appointed
Shriram Sawalram Patel was appointed as Managing Director.

5 earlier events are in the company report.

Frequently asked questions

Enomark Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 06 June 2016 (10+ years old) and is registered under CIN U51909MH2016PTC282093.

Enomark Pharma has 4 current directors:

The latest financial statements of Enomark Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.

The GSTIN of Enomark Pharma is 08AAPCA5656A1ZN, registered in Rajasthan. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Enomark Pharma is U51909MH2016PTC282093. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Enomark Pharma was incorporated on 06 June 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.

Gopa Ram ceased to be Director on 14 Jun 2024. Jetharam Patel was appointed as Director on 14 Jun 2024. Laxmanram Ruparam Patel was appointed as Director on 30 Sep 2023. Enomark Pharma has 12 board changes on record in total.

Yes, Enomark Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-19-0147566).

Enomark Pharma has 1 MSME Form 1 return on record for the period ending Jan 2019, listing 2 overdue payments to 2 micro and small suppliers. The latest return was filed on 09 Jun 2019.

The registered office of Enomark Pharma is at 1A 25 Manali Bldg No. 1 Chs Ltd Evershine Nagar Malad West, Mumbai, Maharashtra, India – 400064.

Enomark Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.